Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.

Shu HF, Yu SX, Zhang CQ, Liu SY, Wu KF, Zang ZL, Yang H, Zhou SW, Yin Q.

Brain Dev. 2013 Mar;35(3):252-60. doi: 10.1016/j.braindev.2012.04.007. Epub 2012 May 28.

PMID:
22647236
2.

Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.

Shu HF, Zhang CQ, Yin Q, An N, Liu SY, Yang H.

J Neuropathol Exp Neurol. 2010 Aug;69(8):838-49. doi: 10.1097/NEN.0b013e3181eaeae5.

PMID:
20613633
3.

Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.

Guo W, Zhang CQ, Shu HF, Yang MH, Yin Q, Yang H.

J Mol Neurosci. 2013 May;50(1):7-13. doi: 10.1007/s12031-012-9841-2. Epub 2012 Jul 3.

PMID:
22752548
4.

Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.

Li S, Yu S, Zhang C, Shu H, Liu S, An N, Yang M, Yin Q, Yang H.

Brain Res. 2012 May 9;1453:46-55. doi: 10.1016/j.brainres.2012.03.009. Epub 2012 Mar 12.

PMID:
22459050
5.

Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.

Boer K, Lucassen PJ, Spliet WG, Vreugdenhil E, van Rijen PC, Troost D, Jansen FE, Aronica E.

Epilepsia. 2009 Dec;50(12):2629-37. doi: 10.1111/j.1528-1167.2009.02191.x. Epub 2009 Jul 2.

6.

Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.

Toering ST, Boer K, de Groot M, Troost D, Heimans JJ, Spliet WG, van Rijen PC, Jansen FE, Gorter JA, Reijneveld JC, Aronica E.

Epilepsia. 2009 Jun;50(6):1409-18. doi: 10.1111/j.1528-1167.2008.01955.x. Epub 2009 Feb 12.

7.

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE.

Ann Neurol. 2012 Apr;71(4):539-51. doi: 10.1002/ana.22696. Epub 2012 Mar 23.

8.

Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.

Zurolo E, Iyer A, Maroso M, Carbonell C, Anink JJ, Ravizza T, Fluiter K, Spliet WG, van Rijen PC, Vezzani A, Aronica E.

Brain. 2011 Apr;134(Pt 4):1015-32. doi: 10.1093/brain/awr032. Epub 2011 Mar 16.

PMID:
21414994
9.

Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.

Boer K, Middeldorp J, Spliet WG, Razavi F, van Rijen PC, Baayen JC, Hol EM, Aronica E.

Epilepsy Res. 2010 Jun;90(1-2):99-109. doi: 10.1016/j.eplepsyres.2010.03.014. Epub 2010 Apr 28.

PMID:
20430588
10.

Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs).

Sugiura C, Miyata H, Ueda M, Ohama E, Vinters HV, Ohno K.

Neuropathology. 2008 Aug;28(4):372-81. doi: 10.1111/j.1440-1789.2007.00881.x. Epub 2008 Jan 3.

PMID:
18179408
11.

Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.

Boer K, Troost D, Timmermans W, Gorter JA, Spliet WG, Nellist M, Jansen F, Aronica E.

Neuroscience. 2008 Sep 22;156(1):203-15. doi: 10.1016/j.neuroscience.2008.06.073. Epub 2008 Jul 25.

PMID:
18706978
12.

Cell injury and premature neurodegeneration in focal malformations of cortical development.

Iyer A, Prabowo A, Anink J, Spliet WG, van Rijen PC, Aronica E.

Brain Pathol. 2014 Jan;24(1):1-17. doi: 10.1111/bpa.12060. Epub 2013 May 7.

PMID:
23586324
13.

Upregulated expression of voltage-gated sodium channel Nav1.3 in cortical lesions of patients with focal cortical dysplasia type IIb.

Yu S, Li S, Shu H, Zhang C, He J, Fan X, Yang H.

Neuroreport. 2012 May 9;23(7):407-11. doi: 10.1097/WNR.0b013e328351db48.

PMID:
22494998
14.

Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.

Yu SX, Li S, Shu HF, Zhang CQ, Liu SY, Yang H.

J Neuropathol Exp Neurol. 2012 Jul;71(7):665-77. doi: 10.1097/NEN.0b013e31825d6585.

PMID:
22710967
15.

Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.

Talos DM, Kwiatkowski DJ, Cordero K, Black PM, Jensen FE.

Ann Neurol. 2008 Apr;63(4):454-65. doi: 10.1002/ana.21342.

16.

Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.

Grajkowska W, Kotulska K, Matyja E, Larysz-Brysz M, Mandera M, Roszkowski M, Domańska-Pakieła D, Lewik-Kowalik J, Jóźwiak S.

Folia Neuropathol. 2008;46(1):43-8.

17.

Expression and cellular distribution of vascular endothelial growth factor-C system in cortical tubers of the tuberous sclerosis complex.

Zhang CQ, Shu HF, Yin Q, An N, Xu SL, Yin JB, Song YC, Liu SY, Yang H.

Brain Pathol. 2012 Mar;22(2):205-18. doi: 10.1111/j.1750-3639.2011.00519.x. Epub 2011 Sep 16.

PMID:
21767323
18.

Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.

Sun FJ, Zhang CQ, Chen X, Wei YJ, Li S, Liu SY, Zang ZL, He JJ, Guo W, Yang H.

J Neuroinflammation. 2016 Apr 19;13(1):85. doi: 10.1186/s12974-016-0546-2.

19.

Detection of human papillomavirus in human focal cortical dysplasia type IIB.

Chen J, Tsai V, Parker WE, Aronica E, Baybis M, Crino PB.

Ann Neurol. 2012 Dec;72(6):881-92. doi: 10.1002/ana.23795.

PMID:
23280839
20.

The interleukin 17 system in cortical lesions in focal cortical dysplasias.

He JJ, Li S, Shu HF, Yu SX, Liu SY, Yin Q, Yang H.

J Neuropathol Exp Neurol. 2013 Feb;72(2):152-63. doi: 10.1097/NEN.0b013e318281262e.

PMID:
23334598

Supplemental Content

Support Center